S-4/A Lays Out Quantum Space Deal Terms: $600M Consideration, $300M PIPE, NYSE Listing
IPFX is trading near its 52-week low of $9.95 (0.5% above the low) on light trading volume (0.1× avg).
Summary
The S-4/A for Inflection Point's merger with Quantum Space puts numbers on the deal: $600 million of consideration to Quantum Space holders, a $300 million PIPE, a $90 million minimum cash condition and a NYSE listing, with Dr. Ghaffarian controlling 78%+ of voting power post-close.
Key Events · M&A and Partnerships · IPFX
-
Quantum Space Deal Terms Quantified
Sellers receive $600,000,000 of aggregate consideration, paid as 59,581,499 New Quantum Space shares at the ~$10.07 per-share redemption price.
-
$300M of New Capital Committed
A $240 million Closing PIPE buys 19,999,994 Series A Preferred shares plus warrants at a $12.00 stated value, alongside a $60 million pre-funded investment of 5,882,352 preferred units and warrants.
-
Ghaffarian to Control 78%+ of Votes
Through ten-vote Class A-2 and Class B-2 shares, Dr. Ghaffarian is expected to hold 78.3% of voting power in the No Redemption Scenario, 80.8% at 50% redemptions and 83.5% at maximum redemptions, making New Quantum Space a controlled company.
-
TRA Diverts 85% of Tax Savings
The Tax Receivable Agreement projects ~$84.0 million of tax savings over 15 years, of which ~$71.4 million is payable to Ghaffarian's affiliate; early termination would cost an estimated ~$52.0 million.
Analysis · IPFX · Manufacturing
Shareholders now have the registration statement they will vote on to approve the Quantum Space business combination, and it attaches hard numbers to a deal previously sketched only in outline. Quantum Space equity holders receive $600 million of consideration, paid as 59,581,499 shares at the ~$10.07 redemption price, while new money arrives through a $240 million Series A Preferred PIPE and a $60 million pre-funded investment — roughly $300 million of fresh capital set against a company that lost $24.9 million in 2025 and carries going-concern doubt. Control is concentrated: Dr. Ghaffarian is expected to hold 78.3%–83.5% of voting power through ten-vote Class A-2/B-2 shares, making New Quantum Space a controlled company, and a Tax Receivable Agreement routes 85% of tax savings (~$71.4 million projected) to his affiliate. Closing depends on shareholder approval, NYSE listing approval and a $90 million minimum cash condition, with a Q4 2026 target and a June 8, 2027 outside date.
How filings like this one have moved
In the 30 days to Oct 23, 2026, 36.8% of the 1044 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.77%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IPFX was trading at $10.00 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $338.3M. The 52-week trading range was $9.95 to $11.02. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.